Lyra Therapeutics Overview
Lyra Therapeutics Discounted Cash Flow
DCF Analysis for LYRA.
Get informed when a big investor buys or sells
+ FollowFair Value
$-3.16
Current Fair Value
$-3.16
↓ 816.9% Downside
Overvalued by 816.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison